February 4, 2009 - The Medical Imaging & Technology Alliance (MITA) responds that the study by Jörg Hausleiter, M.D., in the Feb. 4 issue of the Journal of the American Medical Association (JAMA) correctly focuses on what providers need to know to ensure that computed tomography angiography (CTA) is utilized appropriately.
February 4, 2009 - According to a new market research report released this month by market research firm IMV Medical Information Division, the adoption of 64-slice CT equipment by cardiology practices throughout the U.S. has more than doubled over the past two years.
February 4, 2009 - On Thursday, Feb. 19 at 7:00 pm, The Halifax Health - Center for Cardiology, Daytona Beach, FL will present a live online panel discussion on an automated implantable cardiac defibrillator (ICD) surgical case.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
February 3, 2009 - Bioheart Inc. has arranged with its Italian partner, Biomedica, for a complete grant-supported study of the Bioheart A&C Bio Science T-PLS Twin-Pulsatile Life Support System.
February 3, 2009 – Medtronic has completed enrollment in PROTECT, the company’s global study comparing its Endeavor drug-eluting stent (DES) to Johnson & Johnson’s Cypher DES.
February 2, 2009 - Boston Scientific Corp. today said it began patient enrollment in the PLATINUM clinical trial, which is designed to evaluate the company’s PROMUS Element Everolimus-Eluting Coronary Stent.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
February 2, 2009 - Cardiac Dimensions Inc. today said it received the CE Mark approval for its CARILLON Mitral Contour System from KEMA Quality B.V., a European Union Notified Body from the Netherlands.
February 2, 2009 - CardiArc, Inc., along with Clinical Engineering Consultants Inc. (CEC) of Erlanger, KY, today said CEC will provide field service for the CardiArc HD-SPECT system. CEC also brings technical consultation with CardiArc on the field service manual. In addition CEC will sell the CardiArc system in the Ohio River Valley area.
February 3, 2009 - The FDA has granted Pathway Medical Technologies Inc., 510(k) clearance to market its newest peripheral atherectomy catheter, the Jetstream G2, for use in the treatment of peripheral artery disease (PAD) in the lower limbs.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
February 3, 2009 - Cerenis Therapeutics SA, a privately held pharmaceutical company developing HDL-related compounds for the treatment of cardiovascular and metabolic diseases, has in-licensed intellectual property supporting an investigational new treatment of aortic valve stenosis (AVS) based on HDL therapy.
February 3, 2009 – Barco closed the divestment operation of its Advanced Visualization (AVIS) activities to Toshiba Medical Systems Corp., Tokyo, Japan, in a move by Barco to focus on its medical display systems business.
February 2, 2009 - Diagnosoft Inc. has unveiled its newest software solution, the Diagnosoft SENC. Strain-encoding (SENC).
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
February 2, 2009 - A recent study published in Clinical Cardiology revealed that "emerging risk factors," including detailed cholesterol measurements such as HDL(2) and remnant lipoprotein particles, play a much greater role in determining heart disease risk than previously thought, and that traditional risk factors such as age, standard cholesterol levels and blood pressure do a poor job of predi
February 2, 2009 - An online survey of 1,888 physicians, medical group executives and staff, released today by Allscripts, concludes that U.S. physician groups are eager to accept a proposed multi-billion dollar package of government loans, grants and incentives designed to promote broader adoption of information technologies such as the electronic health record (EHR).
February 2, 2009 - A new multi-center study of 39,821 newborns published in the January 2009 issue of the British Medical Journal (BMJ) found that the addition of Masimo SET pulse oximetry screening before discharge increased detection of congenital heart disease (CHD) by 28 percent from 72 percent to 92 percent when compared to a cohort group of 108,604 newborns in whom no pulse oximetry screenin
February 04, 2009
